The selective mGluR5 agonist CHPG protects against traumatic brain injury in vitro and in vivo via ERK and Akt pathway

Chen,Tao; Zhang,Lei; Qu,Yan; Huo,Kai; Jiang,XiaoFan; Fei,Zhou

doi:10.3892/ijmm.2011.870

The selective mGluR5 agonist CHPG protects against traumatic brain injury in vitro and in vivo via ERK and Akt pathway

Authors:
- Tao Chen
- Lei Zhang
- Yan Qu
- Kai Huo
- XiaoFan Jiang
- Zhou Fei
View Affiliations

Affiliations: Department of Neurosurgery, Xijing Institute of Clinical Neuroscience, Xijing Hospital, Fourth Military Medical University, Xi'an, Shannxi 710032, P.R. China
Published online on: December 28, 2011 https://doi.org/10.3892/ijmm.2011.870
Pages: 630-636

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Group I metabotropic glutamate receptors (mGluRs) have been implicated in the pathophysiology of central nervous system injury, but the role of mGluR5 in traumatic brain injury (TBI) remains unclear. In the present study, we investigated the neuroprotective potency of (R,S)-2-chloro-5-hydroxyphenylglycine (CHPG), a selective mGluR5 agonist, for protecting against TBI in both in vitro and in vivo models. Primary cortical neurons were treated with 1 mM CHPG in an in vitro preparation 30 min before TBI, and 250 nM CHPG was injected into the right lateral ventricle of rats 30 min before TBI was induced in in vivo studies. The results showed that CHPG significantly attenuated lactate dehydrogenase (LDH) release and neuronal apoptosis and reduced lesion volume. Compared to the control or vehicle group, the phosphorylation levels of extracellular signal-regulated kinase (ERK) and Akt were increased in the presence of CHPG, even following the induction of TBI. Furthermore, treatment with either the ERK inhibitor PD98059 or Akt inhibitor LY294002 partially reversed the CHPG's neuroprotective effects. These data suggest that CHPG minimizes brain damage after induction of TBI both in vitro and in vivo, and that these protective effects were possibly mediated by activation of the ERK and Akt signaling pathways. Thus, potentiating mGluR5 activity with selective agonists such as CHPG may be useful for the treatment of traumatic brain injury.

View Figures

View References

1	JA LangloisW Rutland-BrownMM WaldThe epidemiology and impact of traumatic brain injury: a brief overviewJ Head Trauma Rehabil21375378200610.1097/00001199-200609000-0000116983222
2	S YuY KanekoE BaeSeverity of controlled cortical impact traumatic brain injury in rats and mice dictates degree of behavioral deficitsBrain Res1287157163200910.1016/j.brainres.2009.06.06719573519
3	A MammisTK McIntoshAH ManikerErythropoietin as a neuroprotective agent in traumatic brain injury ReviewSurg Neurol71527531200910.1016/j.surneu.2008.02.04018789503
4	JW FinniePC BlumbergsTraumatic brain injuryVet Pathol39679689200210.1354/vp.39-6-679
5	TW McAllisterPsychopharmacological issues in the treatment of TBI and PTSDClin Neuropsychol2313381367200910.1080/1385404090327728919882475
6	RK NarayanME MichelB AnsellClinical trials in head injuryJ Neurotrauma19503557200210.1089/08977150275375403712042091
7	R BullockA ZaunerJJ WoodwardFactors affecting excitatory amino acid release following severe human head injuryJ Neurosurg89507518199810.3171/jns.1998.89.4.05079761042
8	R BullockA ZaunerJS MyserosA MarmarouJJ WoodwardHF YoungEvidence for prolonged release of excitatory amino acids in severe human head trauma. Relationship to clinical eventsAnn NY Acad Sci765290298199510.1111/j.1749-6632.1995.tb16586.x7486616
9	AI FadenP DemediukSS PanterR VinkThe role of excitatory amino acids and NMDA receptors in traumatic brain injuryScience244798800198910.1126/science.25670562567056
10	J SchumannGA AlexandrovichA BiegonR YakaInhibition of NR2B phosphorylation restores alterations in NMDA receptor expression and improves functional recovery following traumatic brain injury in miceJ Neurotrauma25945957200810.1089/neu.2008.0521
11	L YurkewiczJ WeaverMR BullockLF MarshallThe effect of the selective NMDA receptor antagonist traxoprodil in the treatment of traumatic brain injuryJ Neurotrauma2214281443200510.1089/neu.2005.22.142816379581
12	L BelayevOF AlonsoY LiuTalampanel, a novel noncompetitive AMPA antagonist, is neuroprotective after traumatic brain injury in ratsJ Neurotrauma1810311038200110.1089/0897715015269372811686490
13	H HomayounB MoghaddamGroup 5 metabotropic glutamate receptors: role in modulating cortical activity and relevance to cognitionEur J Pharmacol6393339201010.1016/j.ejphar.2009.12.04220371231
14	BG LyethQZ GongS ShieldsJP MuizelaarRF BermanGroup I metabotropic glutamate antagonist reduces acute neuronal degeneration and behavioral deficits after traumatic brain injury in ratsExp Neurol169191199200110.1006/exnr.2001.7643
15	QZ GongTM DelahuntyRJ HammBG LyethMetabotropic glutamate antagonist, MCPG, treatment of traumatic brain injury in ratsBrain Res700299302199510.1016/0006-8993(95)01081-68624726
16	Z FeiX ZhangHM BaiXF JiangXL WangMetabotropic glutamate receptor antagonists and agonists: potential neuroprotectors in diffuse brain injuryJ Clin Neurosci1310231027200610.1016/j.jocn.2005.11.04217113985
17	AI FadenDM O'LearyL FanW BaoPG MullinsVA MovsesyanSelective blockade of the mGluR1 receptor reduces traumatic neuronal injury in vitro and improves outcome after brain traumaExp Neurol167435444200110.1006/exnr.2000.757711161632
18	A MukhinL FanAI FadenActivation of metabotropic glutamate receptor subtype mGluR1 contributes to post-traumatic neuronal injuryJ Neurosci166012602019968815884
19	N MorinL GregoireB Gomez-MancillaF GaspariniT Di PaoloEffect of the metabotropic glutamate receptor type 5 antagonists MPEP and MTEP in parkinsonian monkeysNeuropharmacology58981986201010.1016/j.neuropharm.2009.12.02420074579
20	A CopaniG CasabonaV BrunoThe metabotropic glutamate receptor mGlu5 controls the onset of developmental apoptosis in cultured cerebellar neuronsEur J Neurosci1021732184199810.1046/j.1460-9568.1998.00230.x9753103
21	A CopaniV BrunoG BattagliaActivation of metabotropic glutamate receptors protects cultured neurons against apoptosis induced by beta-amyloid peptideMol Pharmacol4789089719957746277
22	X XuCC ChuaJ GaoNeuroprotective effect of humanin on cerebral ischemia/reperfusion injury is mediated by a PI3K/Akt pathwayBrain Res12271218200810.1016/j.brainres.2008.06.01818590709
23	B GuerraM DiazR AlonsoR MarinPlasma membrane oestrogen receptor mediates neuroprotection against beta-amyloid toxicity through activation of Raf-1/MEK/ERK cascade in septal-derived cholinergic SN56 cellsJ Neurochem9199109200410.1111/j.1471-4159.2004.02695.x
24	L HouE KlannActivation of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway is required for metabotropic glutamate receptor-dependent long-term depressionJ Neurosci2463526361200410.1523/JNEUROSCI.0995-04.200415254091
25	ES ChoeJQ WangGroup I metabotropic glutamate receptor activation increases phosphorylation of cAMP response element-binding protein, Elk-1, and extracellular signal-regulated kinases in rat dorsal striatumBrain Res Mol Brain Res947584200110.1016/S0169-328X(01)00217-0
26	L RedmondAH KashaniA GhoshCalcium regulation of dendritic growth via CaM kinase IV and CREB-mediated transcriptionNeuron349991010200210.1016/S0896-6273(02)00737-712086646
27	WD HuangZ FeiX ZhangTraumatic injury induced homer-1a gene expression in cultured cortical neurons of ratNeurosci Lett3894650200510.1016/j.neulet.2005.07.01416087291
28	M FukushimaSM LeeN MoroDA HovdaRL SuttonMetabolic and histologic effects of sodium pyruvate treatment in the rat after cortical contusion injuryJ Neurotrauma2610951110200910.1089/neu.2008.077119594384
29	R LujanZ NusserJD RobertsR ShigemotoP SomogyiPerisynaptic location of metabotropic glutamate receptors mGluR1 and mGluR5 on dendrites and dendritic spines in the rat hippocampusEur J Neurosci814881500199610.1111/j.1460-9568.1996.tb01611.x8758956
30	C RomanoMA SesmaCT McDonaldK O'MalleyAN Van den PolJW OlneyDistribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brainJ Comp Neurol355455469199510.1002/cne.9035503107636025
31	VA MovsesyanDM O'LearyL FanmGluR5 antagonists 2-methyl-6-(phenylethynyl)-pyridine and (E)-2-methyl-6-(2-phenylethenyl)-pyridine reduce traumatic neuronal injury in vitro and in vivo by antagonizing N-methyl-D-aspartate receptorsJ Pharmacol Exp Ther29641472001
32	VA MovsesyanBA StoicaAI FadenMGLuR5 activation reduces beta-amyloid-induced cell death in primary neuronal cultures and attenuates translocation of cytochrome c and apoptosis-inducing factorJ Neurochem8915281536200410.1111/j.1471-4159.2004.02451.x15189356
33	F LiuX GongG ZhangK MarquisP ReinhartTH AndreeThe inhibition of glycogen synthase kinase 3beta by a metabotropic glutamate receptor 5 mediated pathway confers neuroprotection to Abeta peptidesJ Neurochem9513631372200510.1111/j.1471-4159.2005.03474.x16277616
34	AJ DohertyMJ PalmerJM HenleyGL CollingridgeDE Jane(RS)-2-chloro-5-hydroxyphenylglycine (CHPG) activates mGlu5, but no mGlu1, receptors expressed in CHO cells and potentiates NMDA responses in the hippocampusNeuropharmacology36265267199710.1016/S0028-3908(97)00001-49144665
35	L YangL MaoQ TangS SamdaniZ LiuJQ WangA novel Ca²⁺-independent signaling pathway to extracellular signal-regulated protein kinase by coactivation of NMDA receptors and metabotropic glutamate receptor 5 in neuronsJ Neurosci2410846108572004
36	Y KurokiK FukushimaY KandaK MizunoY WatanabeNeuroprotection by estrogen via extracellular signal-regulated kinase against quinolinic acid-induced cell death in the rat hippocampusEur J Neurosci13472476200110.1046/j.0953-816x.2000.01409.x11168553
37	Y ZhuGY YangB AhlemeyerTransforming growth factor-beta 1 increases bad phosphorylation and protects neurons against damageJ Neurosci2238983909200212019309
38	PK DashSA MachAN MooreThe role of extracellular signal-regulated kinase in cognitive and motor deficits following experimental traumatic brain injuryNeuroscience114755767200210.1016/S0306-4522(02)00277-412220576
39	CM AtkinsAA Oliva JrOF AlonsoHypothermia treatment potentiates ERK1/2 activation after traumatic brain injuryEur J Neurosci26810819200710.1111/j.1460-9568.2007.05720.x17666079
40	K FukunagaT KawanoAkt is a molecular target for signal transduction therapy in brain ischemic insultJ Pharmacol Sci92317327200310.1254/jphs.92.31712939516
41	CJ MullonkalLH Toledo-PereyraAkt in ischemia and reperfusionJ Invest Surg20195203200710.1080/0894193070136647117613695
42	ZZ ChongF LiK MaieseActivating Akt and the brain's resources to drive cellular survival and prevent inflammatory injuryHistol Histopathol202993152005
43	MH CardoneN RoyHR StennickeRegulation of cell death protease caspase-9 by phosphorylationScience28213181321199810.1126/science.282.5392.13189812896
44	SR DattaH DudekX TaoAkt phosphorylation of BAD couples survival signals to the cell-intrinsic death machineryCell91231241199710.1016/S0092-8674(00)80405-59346240
45	GM LeinningerC BackusMD UhlerSI LentzEL FeldmanPhosphatidylinositol 3-kinase and Akt effectors mediate insulin-like growth factor-I neuroprotection in dorsal root ganglia neuronsFASEB J1815441546200415319368
46	S PugazhenthiA NesterovaC SableAkt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding proteinJ Biol Chem2751076110766200010.1074/jbc.275.15.1076110753867
47	G MajnoI JorisApoptosis, oncosis, and necrosis. An overview of cell deathAm J Pathol14631519957856735
48	PG SullivanJN KellerWL BussenSW ScheffCytochrome c release and caspase activation after traumatic brain injuryBrain Res9498896200210.1016/S0006-8993(02)02968-212213303